WorldPingSTAT
STAT+: FDA approves Roivant therapy for rare autoimmune disease
WorldPingThe FDA approved a new medicine from Roivant and its subsidiary Priovant for the treatment of dermatomyositis, a rare autoimmune disease.
This is a short WorldPing brief. The full report was published by STAT.
Read the full report at STAT